Communique # 40
18 March, 2021
WEEK IN REVIEW UPDATES TO THE LIVING GUIDELINE New recommendation for tocilizumab in children or adolescents Further to the Taskforce's recent recommendation for the conditional use of tocilizumab for adults (25 February 2021), the Paediatric and Adolescent Care Panel have reviewed the evidence in the context of this special population, also consulting with members of the Expert Advisory Group in rheumatology, immunotherapy and paediatric...